Vivos Therapeutics (VVOS) said Wednesday it struck a deal to buy the operating assets of The Sleep Center of Nevada for up to $9 million, including $6 million in cash and $1.5 million in shares.
The transaction, expected to close in Q2 or Q3, does not require Vivos shareholder approval, the company said. It plans to secure funding with a senior debt facility, and potential equity financing.
With the acquisition, the company said it plans to make its treatments for obstructive sleep apnea available to thousands of patients in the greater Las Vegas metro area.
Price: 2.10, Change: -0.09, Percent Change: -4.11
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。